GoodRx Holdings, Inc. - Common Stock (GDRX)

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock
Shares outstanding
98,685,316
Total 13F shares
141,637,249
Share change
+3,784,034
Total reported value
$948,962,237
Put/Call ratio
110%
Price per share
$6.70
Number of holders
138
Value change
+$31,081,244
Number of buys
56
Number of sells
81

Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q4 2023

As of 31 Dec 2023, GoodRx Holdings, Inc. - Common Stock (GDRX) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 141,637,249 shares. The largest 10 holders included Francisco Partners Management, LP, VANGUARD GROUP INC, AMERIPRISE FINANCIAL INC, Rubric Capital Management LP, Silver Lake Group, L.L.C., RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, LAKEWOOD CAPITAL MANAGEMENT, LP, Petrus Trust Company, LTA, and BlackRock Inc.. This page lists 138 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.